Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 9c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Standard Uranium extends private placement closing date to October 18
• HP shares slide as tech giant forecasts 2027 PC market slump